B. Fernie-King

发表

Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics.

J. Sallenave, P. Lachmann, P. Hiemstra, 2004, Current pharmaceutical design.

Functional characterization of DRS from Streptococcus pyogenes M12 and M55 serotypes

P. Lachmann, K. S. Sriprakash, M. Binks, 2006 .

Mapping of functional domains of streptococcal inhibitor of complement (SIC)

P. Lachmann, K. S. Sriprakash, M. Binks, 2006 .

Inhibition of antimicrobial peptides by group A streptococci: SIC and DRS.

P. Lachmann, B. Fernie-King, D. Seilly, 2006, Biochemical Society transactions.

Attribution of the Various Inhibitory Actions of the Streptococcal Inhibitor of Complement (SIC) to Regions within the Molecule*

P. Lachmann, K. S. Sriprakash, M. Binks, 2005, Journal of Biological Chemistry.

The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins

P. Lachmann, B. Fernie-King, D. Seilly, 2004, Immunology.

Streptococcal DRS (distantly related to SIC) and SIC inhibit antimicrobial peptides, components of mucosal innate immunity: a comparison of their activities.

P. Lachmann, K. S. Sriprakash, M. Binks, 2007, Microbes and infection.

Streptococcal Inhibitor of Complement Inhibits Two Additional Components of the Mucosal Innate Immune System: Secretory Leukocyte Proteinase Inhibitor and Lysozyme

P. Lachmann, A. Davies, B. Fernie-King, 2002, Infection and Immunity.

Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes

P. Lachmann, R. Würzner, A. Davies, 2001, Immunology.

Subversion of the innate immune response by micro-organisms

P. Lachmann, A. Davies, B. Fernie-King, 2002, Annals of the rheumatic diseases.